Patent directory · USPTO A61K / A61P
Patents matching “Vaximm AG”
10 pharma patents match "Vaximm AG" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 10 pharmaceutical patents matching "Vaximm AG" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11357842
PD-L1 targeting DNA vaccine for cancer immunotherapy
granted -
US 10980868
VEGFR-2 targeting immunotherapy approach
granted -
US 10905752
VEGFR-2 targeting DNA vaccine for combination therapy
granted -
US 10821163
Process for the production of a DNA vaccine for cancer immunotherapy
granted -
US 10815455
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
granted -
US 10441645
MSLN targeting DNA vaccine for cancer immunotherapy
granted -
US 10293037
DNA vaccine for use in pancreatic cancer patients
granted -
US 9920297
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1
granted -
US 9493738
Method for producing high yield attenuated Salmonella strains
granted -
US 9415098
DNA vaccine for use in pancreatic cancer patients
granted